Leanbio
Leanbio is a global CDMO providing development and manufacturing services for biopharmaceutical products, specializing in efficient processes and innovative, reliable biomanufacturing solutions. Since 2014, they focus on supporting clients from early development to commercial production, with a talented, interdisciplinary team and state-of-the-art facilities in Barcelona. They are committed to biologics innovation, sustainability, and accelerating success in the biotech industry.
Industries
Nr. of Employees
small (1-50)
Products
Leanbio Biopharmaceutical CDMO Services
End-to-end biopharmaceutical development and manufacturing services spanning early-stage development to commercial production, covering various expression systems and therapeutic proteins including mAbs, bispecifics, antibody fragments, enzymes, fusion proteins, hormones, peptides, bioconjugates like ADC, mRNA, and plasmid DNA.
Bioconjugates
Specialized services for antibody-drug conjugates (ADCs) and protein-drug conjugates (PDCs), offering tailored processes for high-quality bioconjugation, purification, and cGMP release.
Cell Banking Services
Providing secure, scalable, and GMP-compliant solutions to ensure quality, stability, and regulatory compliance for your biologics development and manufacturing.
pDNA and mRNA CDMO Services
Customized plasmid DNA and mRNA development and manufacturing services to streamline bioprocessing.
Preclinical Manufacturing
Accelerating early-stage biologics development with scalable, high-quality production tailored to preclinical research, pharmacology, and toxicology studies.
mRNA manufacturing solutions
Comprehensive, end-to-end mRNA manufacturing solutions for preclinical, clinical, and commercial applications under cGMP conditions.
Leanbio Biopharmaceutical CDMO Services
End-to-end biopharmaceutical development and manufacturing services spanning early-stage development to commercial production, covering various expression systems and therapeutic proteins including mAbs, bispecifics, antibody fragments, enzymes, fusion proteins, hormones, peptides, bioconjugates like ADC, mRNA, and plasmid DNA.
Bioconjugates
Specialized services for antibody-drug conjugates (ADCs) and protein-drug conjugates (PDCs), offering tailored processes for high-quality bioconjugation, purification, and cGMP release.
Cell Banking Services
Providing secure, scalable, and GMP-compliant solutions to ensure quality, stability, and regulatory compliance for your biologics development and manufacturing.
pDNA and mRNA CDMO Services
Customized plasmid DNA and mRNA development and manufacturing services to streamline bioprocessing.
Preclinical Manufacturing
Accelerating early-stage biologics development with scalable, high-quality production tailored to preclinical research, pharmacology, and toxicology studies.
mRNA manufacturing solutions
Comprehensive, end-to-end mRNA manufacturing solutions for preclinical, clinical, and commercial applications under cGMP conditions.
Services
Cross‑functional transfer and assessment of processes, equipment and documentation to enable scale-up or transfer between sites/stages.
Development of stable, high‑expression cell lines with single‑cell cloning and optimization for production.
Custom upstream and downstream process design, optimization and scale‑up including purification workflows and formulation development.
Analytical method development, CQA identification and comprehensive characterization for proteins and nucleic acids.
GMP‑compliant generation, characterization and temperature‑controlled storage of Master and Working Cell Banks with stability programs.
Flexible non‑GMP and pilot manufacturing for preclinical studies, including batch records and IND/IMPD‑enabling documentation.
Cross‑functional transfer and assessment of processes, equipment and documentation to enable scale-up or transfer between sites/stages.
Development of stable, high‑expression cell lines with single‑cell cloning and optimization for production.
Custom upstream and downstream process design, optimization and scale‑up including purification workflows and formulation development.
Analytical method development, CQA identification and comprehensive characterization for proteins and nucleic acids.
GMP‑compliant generation, characterization and temperature‑controlled storage of Master and Working Cell Banks with stability programs.
Flexible non‑GMP and pilot manufacturing for preclinical studies, including batch records and IND/IMPD‑enabling documentation.
Expertise Areas
- Contract development and manufacturing (CDMO) for biologics
- Cell line development and cell banking
- Upstream and downstream process development
- Analytical development and bioassays
Key Technologies
- Single-use bioreactors
- In vitro transcription (IVT) for mRNA
- Chromatography (SEC, RP, IEX, HILIC)
- HPLC-MALS
News & Updates
The biopharmaceutical production plant in Sant Quirze del Vallés, currently under construction, will become one of the most advanced in Europe, supporting the manufacturing of recombinant proteins, antibodies, plasmid DNA, and mRNA for advanced therapies.
The biopharmaceutical production plant in Sant Quirze del Vallés, currently under construction, will become one of the most advanced in Europe, supporting the manufacturing of recombinant proteins, antibodies, plasmid DNA, and mRNA for advanced therapies.